Ethamolin 5% ampul 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FW4FB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,497
Award facts
- Contract value 100% obligated
- $26,497.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,497.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ethamolin 5% ampuls (2ml) on January 29, 2026, with a completion date of January 30, 2026. This non-set-aside contract was competitively awarded and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office operations.
Ethamolin is a sclerosing agent primarily used in medical procedures for the treatment of esophageal varices and other vascular conditions. The delivery order supports the Defense Health Agency's pharmaceutical supply chain needs for military healthcare systems. AmerisourceBergen, as a major pharmaceutical distributor, has demonstrated substantial capability in fulfilling federal medical procurement requirements through its comprehensive portfolio of brand-name and generic medications, specialty pharmaceuticals, and medical supplies across multiple therapeutic domains. The broader IDC vehicle enables DLA to leverage AmerisourceBergen's global supply chain capabilities to support military treatment facilities and healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FW4FB?
SPE2DR26FW4FB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FW4FB worth?
The government has obligated $26,497 on SPE2DR26FW4FB.
Is contract SPE2DR26FW4FB an order under another contract?
Yes. SPE2DR26FW4FB is a delivery order under SPE2DR25D7067, an indefinite delivery contract.
Was contract SPE2DR26FW4FB competed?
The extent of competition for SPE2DR26FW4FB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award